menu
    • menu

    Company profile for Tavros Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tavros Therapeutics is discovering and developing first-in-class, targeted cancer therapies. We are a science-first company and believe the future of cancer therapy lies in identifying how to best position drugs in the clinic through a deep understanding of drug biology. We use cutting-edge functional genomics technologies to uncover unique vulnerabilities within the tumor to discover context-specific cancer drugs, targets, an...
    Tavros Therapeutics is discovering and developing first-in-class, targeted cancer therapies. We are a science-first company and believe the future of cancer therapy lies in identifying how to best position drugs in the clinic through a deep understanding of drug biology. We use cutting-edge functional genomics technologies to uncover unique vulnerabilities within the tumor to discover context-specific cancer drugs, targets, and approaches. We are driven to make an impact on cancer by developing the next generation of targeted cancer therapies to dramatically improve outcomes for cancer patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tavros TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 West Main St, Suite 200 Durham, NC 27701
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tavrostx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tavros-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vividion Acquires Tavros To Enhance Functional Genomics Platform
    Vividion Acquires Tavros To Enhance Functional Genomics Platform

    08 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250108967074/en

    BUSINESSWIRE
    08 Jan 2025
    Share Share
    Tavros Achieves Two Milestones In Vividion Collaboration
    Tavros Achieves Two Milestones In Vividion Collaboration

    14 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/14/2881260/0/en/Tavros-Therapeutics-Achieves-Two-Milestone-Payments-in-its-Collaboration-with-Vividion-Therapeutics.html

    GLOBENEWSWIRE
    14 May 2024
    Share Share
    Tavros achieves milestones in collaboration with Bayer’s Vividion
    Tavros achieves milestones in collaboration with Bayer’s Vividion

    14 May 2024

    // BIOSPACE

    https://www.biospace.com/article/releases/tavros-therapeutics-achieves-two-milestone-payments-in-its-collaboration-with-vividion-therapeutics-agreement-includes-the-discovery-and-enhancement-of-targeted-oncology-drug-targets-and-biomarkers-in-addition-to-positioning-existing-compounds/#:~:text=Webinars%20(9)-,Tavros%20Therapeutics%20Achieves%20Two%20Milestone%20Payments%20in%20its%20Collaboration%20with,addition%20to%20positioning%20existing%20compounds

    BIOSPACE
    14 May 2024
    Share Share
    Tavros Therapeutics and OpenBench Expand Strategic Collaboration
    Tavros Therapeutics and OpenBench Expand Strategic Collaboration

    27 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/27/2656328/0/en/Tavros-Therapeutics-and-OpenBench-Expand-Strategic-Collaboration-for-Small-Molecule-Drug-Discovery.html

    GLOBENEWSWIRE
    27 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search